Syndax Pharmaceuticals Inc

XNAS:SNDX 4:00:00 PM EDT

18.25

+0.34 (+1.90%)

7:56:38 PM EDT: $18.59 +0.34 (+1.86%)

Market Cap (Intraday)	1.65B
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$79.8 Million
Adjusted EPS	-$0.48

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

Syndax Pharmaceuticals Inc Stock, XNAS:SNDX

730 Third Avenue, floor 9, New York, New York 10017

United States of America

Phone: +1.781.419.1400

Number of Employees: 270

http://www.syndax.com

Description

Syndax Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company engaged in the development of cancer therapies. Its product candidates include SNDX-5613 and SNDX-6352. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in New York, NY.